Cadila Healthcare inches up on receiving EIR for Ankleshwar unit

23 Sep 2019 Evaluate

Cadila Healthcare is currently trading at Rs. 247.65, up by 0.40 points or 0.16% from its previous closing of Rs. 247.25 on the BSE.

The scrip opened at Rs. 249.40 and has touched a high and low of Rs. 253.15 and Rs. 242.50 respectively. So far 54273 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 414.60 on 21-Sep-2018 and a 52 week low of Rs. 206.45 on 22-Aug-2019.

Last one week high and low of the scrip stood at Rs. 253.15 and Rs. 234.65 respectively. The current market cap of the company is Rs. 25255.73 crore.

The promoters holding in the company stood at 74.79%, while Institutions and Non-Institutions held 16.29% and 8.79% respectively.

Cadila Healthcare’s API manufacturing facility located at Ankleshwar (Unit 1) in Gujarat has received an Establishment Inspection Report (EIR). The US Food and Drug Administration (USFDA) had conducted an inspection at the facility from July 22 to 26, 2019. The EIR report stated that the classification of the facility is ’No Action Indicated (NAI)’

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.

Zydus Lifesciences Share Price

881.95 -2.90 (-0.33%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×